1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
    Journal Article

    Chan, J. M.; Quintanal-Villalonga, Á; Gao, V. R.; Xie, Y.; Allaj, V.; Chaudhary, O.; Masilionis, I.; Egger, J.; Chow, A.; Walle, T.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • WNT as a driver and dependency in cancer
    Review

    Parsons, M. J.; Tammela, T.; Dow, L. E.
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • A novel NIPBL-NACC1 gene fusion is characteristic of the cholangioblastic variant of intrahepatic cholangiocarcinoma
    Journal Article

    Argani, P.; Palsgrove, D. N.; Anders, R. A.; Smith, S. C.; Saoud, C.; Kwon, R.; Voltaggio, L.; Assarzadegan, N.; Oshima, K.; Rooper, L.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Non-covalent coatings on carbon nanotubes mediate photosensitizer interactions
    Journal Article

    Horoszko, C. P.; Schnatz, P. J.; Budhathoki-Uprety, J.; Rao-Pothuraju, R. V.; Koder, R. L.; Heller, D. A.
    ACS Applied Materials & Interfaces (2021)

    Fulltext@MSK | Save
  • Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Avecilla, S.; Boulad, F.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Boulad, F.; Zhang, J.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • POLQ knockout induces synthetic lethality in HR-deficient pancreatic cancer
    Meeting Abstract

    Oh, G.; Wang, A.; Wang, L.; Li, J.; Zhao, E.; Werba, G.; Wan, S.; Sfeir, A.; Simeone, D. M.
    Pancreas (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, Á.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Ciampricotti, M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal‐Villalonga, Á.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J. M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
    Meeting Abstract

    Rudin, C. M.; Abida, W.; Spira, A.; Chadha, R.; Yang, J.; Powers, D.; Coleman, R.
    Annals of Oncology (2021)

    Fulltext@MSK | Save